Skip to content

Clinical trials

Observational Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Observational Country / region: Italy Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20103
20121
20133
20143
20151
20171
20201
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Unknown status4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gruppo Italiano Malattie EMatologiche dell'Adulto10
University of Milano Bicocca2
Azienda USL Reggio Emilia - IRCCS1
Bristol-Myers Squibb1
Carmen Fava1
University of Pisa1
University of Turin, Italy1
Università degli Studi di Brescia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive18
Cardiovascular Diseases1
Erectile Dysfunction1
Hodgkin Disease1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid, Chronic-Phase1
Myelodysplastic Syndromes1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.